Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China · Delayed Price · Currency is CNY 43.01
-0.19 (-0.44%)
Feb 27, 2026, 3:00 PM CST
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 29.4 billion as of February 27, 2026. Its market cap has increased by 44.61% in one year.
Market Cap
29.40B
Enterprise Value
27.71B
Revenue
5.37B
Ranking
n/a
PE Ratio
9.23
Stock Price
43.01
Market Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 29.40B, an increase of 325.21%. That is a compound annual growth rate of 6.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 29.40B | -4.47% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Changchun High-Tech Industry (Group) | 35.63B |
| Dong-E-E-Jiao | 35.43B |
| Humanwell Healthcare (Group) | 31.60B |
| Shijiazhuang Yiling Pharmaceutical | 29.67B |
| Livzon Pharmaceutical Group | 28.48B |
| Chengdu Kanghong Pharmaceutical Group | 26.55B |
| Kangmei Pharmaceutical | 26.41B |
| Hubei Jumpcan Pharmaceutical | 25.29B |